This inventor holds 1 USPTO granted patent. Top assignee: Vyzkumny Ustav Pro Farmacii a Biochemii, Statni Podnik. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Jiri Kejha: Innovator in Pharmaceutical Chemistry
Introduction
Jiri Kejha is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly with his innovative compounds that exhibit therapeutic properties. His work focuses on developing new medications that can improve patient outcomes.
Latest Patents
Jiri Kejha holds a patent for the compound 5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid, also known as DISALAZINE. This invention relates to a new compound that possesses anti-arthritic and immunomodulating properties. The compound can be synthesized through the reaction of the diazonium salt of sulfadimidine with salicylic acid, followed by acetylation of the resulting product. This innovative approach has the potential to provide new treatment options for patients suffering from arthritis.
Career Highlights
Jiri Kejha is affiliated with the Research Institute for Pharmacy and Biochemistry, a state enterprise dedicated to advancing pharmaceutical research. His work at this institution has allowed him to explore various aspects of drug development and contribute to the scientific community.
Collaborations
Throughout his career, Jiri has collaborated with several talented individuals, including Bohumila Brunova and Darina Slukova. These collaborations have fostered a productive environment for research and innovation in the pharmaceutical field.
Conclusion
Jiri Kejha's contributions to pharmaceutical chemistry, particularly through his patent for DISALAZINE, highlight his commitment to advancing medical science. His work continues to inspire future innovations in the treatment of arthritis and other related conditions.